Skip to main content
. 2021 Jan 21;10:610636. doi: 10.3389/fonc.2020.610636

Table 5.

Toxicity from stereotactic body radiotherapy (SBRT) in patients with positive margin.

Toxicity grade (CTCAE) 0 1 2 3 4
Myeloid suppression
 Leukopenia 4 (44.4%) 5 (55.6%) 0 (0%) 0 (0%) 0 (0%)
 Lymphopenia 8 (88.9%) 1 (11.1%) 0 (0%) 0 (0%) 0 ()%)
 Thrombocytopenia 7 (77.8%) 1 (11.1%) 1 (11.1%) 0 (0%) 0 (0%)
Constitutional symptoms
 Fatigue 7 (77.8%) 2 (22.2%) 0 (0%) 0 (0%) 0 (0%)
 Fever (tympanic) 9 (100.0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 Insomnia 9 (100.0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 Abdominal pain 9 (100.0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Gastrointestinal
 Anorexia 9 (100.0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 Diarrhea 9 (100.0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 Constipation 9 (100.0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 Nausea 8 (88.9%) 1 (11.1%) 0 (0%) 0 (0%) 0 (0%)
 Vomiting 8 (88.9%) 1 (11.1%) 0 (0%) 0 (0%) 0 (0%)
Metabolic/laboratory
 Albumin 9 (100.0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 Liver transaminase (ALT or AST) 5 (55.6%) 4 (44.4%) 0 (0%) 0 (0%) 0 (0%)
 Bilirubin 6 (66.7%) 3 (33.3%) 0 (0%) 0 (0%) 0 (0%)
Radiation induced liver disease (RILD) 9 (100.0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)